Does endothelial nitric oxide synthase gene variation play a role in the occurrence of hypertension in pregnancy?

Hypertens Pregnancy. 2003;22(2):149-55. doi: 10.1081/PRG-120021061.

Abstract

Objective: Nitric oxide is suggested to play a role in the development of preeclampsia.

Methods: We studied 61 patients with gestational hypertension (GH), 77 with GH and significant proteinuria (urine protein excretion > or = 300 mg/24 h), 82 with essential hypertension (EH) and 188 normotensive women with at least one normal pregnancy.

Main outcome measure(s): A polymorphism within the constitutive endothelial nitric oxide synthase (ecNOS) gene in various types of hypertension in pregnancy was explored.

Results: Allelic and genotypic frequencies did not differ between controls and case groups. A significant difference was observed between the frequency of the rare allele in GH patients and that in EH group (chi2: 4.47, P <.04). This difference approximated the significance when GH subjects with or without proteinuria were grouped (chi2 square: 3.33; P =.068). Cigarette smoking or gravidity did not interact with the ecNOS polymorphism in identifying different types of hypertension in this setting.

Conclusion: Our findings argue against an association between ecNOS polymorphism and preeclampsia and support the hypothesis for a different pathogenesis of GH in respect to EH.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Alleles
  • Analysis of Variance
  • Base Sequence
  • Case-Control Studies
  • Confidence Intervals
  • Female
  • Follow-Up Studies
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Hypertension / epidemiology
  • Hypertension / genetics*
  • Incidence
  • Logistic Models
  • Molecular Sequence Data
  • Nitric Oxide Synthase / genetics*
  • Odds Ratio
  • Polymerase Chain Reaction
  • Polymorphism, Genetic*
  • Pregnancy
  • Pregnancy Complications, Cardiovascular / diagnosis*
  • Pregnancy Complications, Cardiovascular / epidemiology
  • Pregnancy Outcome*
  • Risk Assessment

Substances

  • Nitric Oxide Synthase